Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-25-061752

Director sold 23,500 shares at $48.79 ($1,146,565)

  • Director acquired 23,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Moukheibir Catherine Director 2025-07-03 Option exercise +23,500 23,500 D: show line 1 in the form
Moukheibir Catherine Director 2025-07-03 Sale −23,500 $48.79 $1,146,565 0 D: show line 2 in the form
Open-market sales · 23,500 sh · avg $48.79 · $1,146,565

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Moukheibir Catherine Director 2025-07-03 Option exercise · Option to Buy −23,500 21,500 D: show line 3 in the form
Loading xslF345X05/ownership.xml…